These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 17967823)

  • 1. Failure of investigator adherence to electrocardiographic entry criteria is frequent and influences clinical outcomes: lessons from APEX-AMI.
    Tjandrawidjaja MC; Fu Y; Al-Khalidi H; Todaro TG; Adams P; Van de Werf F; Granger CB; Armstrong PW;
    Eur Heart J; 2007 Dec; 28(23):2850-7. PubMed ID: 17967823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
    Brener SJ; Westerhout CM; Fu Y; Todaro TG; Moliterno DJ; Wagner GS; Granger CB; Armstrong PW;
    Am Heart J; 2009 Nov; 158(5):755-60. PubMed ID: 19853693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).
    Patel MR; Pfisterer ME; Betriu A; Widmisky P; Holmes DR; O'Neill WW; Stebbins A; Van de Werf F; Armstrong PW; Granger CB;
    Am J Cardiol; 2009 Jan; 103(2):181-6. PubMed ID: 19121433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous reperfusion in ST-elevation myocardial infarction: comparison of angiographic and electrocardiographic assessments.
    Bainey KR; Fu Y; Wagner GS; Goodman SG; Ross A; Granger CB; Van de Werf F; Armstrong PW;
    Am Heart J; 2008 Aug; 156(2):248-55. PubMed ID: 18657653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial.
    Toma M; Fu Y; Ezekowitz JA; McAlister FA; Westerhout CM; Granger CB; Armstrong PW
    Am Heart J; 2010 Oct; 160(4):671-7. PubMed ID: 20934561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
    Koeth O; Zahn R; Gitt AK; Bauer T; Juenger C; Senges J; Zeymer U;
    Am J Cardiol; 2009 Oct; 104(8):1074-7. PubMed ID: 19801027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial.
    Scirica BM; Morrow DA; Budaj A; Dalby AJ; Mohanavelu S; Qin J; Aroesty J; Hedgepeth CM; Stone PH; Braunwald E
    J Am Coll Cardiol; 2009 Apr; 53(16):1411-21. PubMed ID: 19371824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of QRS duration at baseline and changes over 60 min after fibrinolysis to 30-day mortality with different locations of ST elevation myocardial infarction: results from the Hirulog and Early Reperfusion or Occlusion-2 trial.
    Wong CK; Gao W; Stewart RA; French JK; Aylward PE; White HD
    Heart; 2009 Feb; 95(4):276-82. PubMed ID: 19074924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIb.
    Mehta RH; Rao SV; Ohman EM; Bates ER; Marcucci G; Zhang M; Pieper KS; Armstrong PW; White HD; Van de Werf F; Califf RM; Granger CB
    Eur Heart J; 2008 Apr; 29(7):880-7. PubMed ID: 18334473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of the admission and predischarge electrocardiogram in acute coronary syndromes: the GUSTO-IIb ECG Core Laboratory experience.
    Goodman SG; Fu Y; Langer A; Barr A; Tan M; Wagner GS; Barbagelata A; Sgarbossa EB; Birnbaum Y; Granger CB; Califf RM; Van de Werf F; Topol EJ; Armstrong PW;
    Am Heart J; 2006 Aug; 152(2):277-84. PubMed ID: 16875908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials.
    Kang S; Yang Y; Li CJ; Gao R
    Clin Ther; 2007 Nov; 29(11):2406-18. PubMed ID: 18158081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry).
    Kuch B; von Scheidt W; Kling B; Heier M; Hoermann A; Meisinger C
    Am J Cardiol; 2008 Nov; 102(9):1125-30. PubMed ID: 18940277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Armstrong PW; Adams PX; Al-Khalidi HR; Hamm C; Holmes D; O'Neill W; Todaro TG; Vahanian A; Van de Werf F; Granger CB;
    Am Heart J; 2005 Mar; 149(3):402-7. PubMed ID: 15864228
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Lev EI; Kornowski R; Vaknin-Assa H; Porter A; Teplitsky I; Ben-Dor I; Brosh D; Fuchs S; Battler A; Assali A
    Am J Cardiol; 2008 Jul; 102(1):6-11. PubMed ID: 18572028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Mahaffey KW; Wampole JL; Stebbins A; Berdan LG; McAfee D; Rorick TL; French JK; Kleiman NS; O'Connor CM; Cohen EA; Granger CB; Armstrong PW;
    Contemp Clin Trials; 2011 Mar; 32(2):178-87. PubMed ID: 21220052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validity of clinical trials in acute myocardial infarction.
    Steg PG; López-Sendón J; Lopez de Sa E; Goodman SG; Gore JM; Anderson FA; Himbert D; Allegrone J; Van de Werf F;
    Arch Intern Med; 2007 Jan; 167(1):68-73. PubMed ID: 17210880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study.
    De Luca L; Bolognese L; Casella G; Savonitto S; Gonzini L; Di Chiara A; De Servi S; Notaristefano S; Valagussa L; Maggioni AP; Chiarella F;
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1045-51. PubMed ID: 18799968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electrocardiographic changes in patients presenting with an acute coronary syndrome: "apical ballooning" versus anterior myocardial infarction].
    Peters K; Stein J; Schneider B
    Dtsch Med Wochenschr; 2008 Apr; 133(16):823-8. PubMed ID: 18398790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the spectrum of left bundle branch block in acute myocardial infarction: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT 2 and 3) trials.
    Al-Faleh H; Fu Y; Wagner G; Goodman S; Sgarbossa E; Granger C; Van de Werf F; Wallentin L; Armstrong PW;
    Am Heart J; 2006 Jan; 151(1):10-5. PubMed ID: 16368285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.